March 31, 2020

Pharmaceutical Rapid Microbiology Testing Market Is Expected To Reach Worth USD 6.2 Bn by 2022

According to the latest report published by Credence Research, Inc. “Pharmaceutical Rapid Microbiology Testing Market – Growth, Future Prospects, and Competitive Analysis, 2016-2022,” the global market for rapid pharmaceutical microbiology testing was valued at USD 3.4 billion in 2015 and is expected to reach USD 6.2 billion by 2022, increasing to CAGR by 7.3 per cent from 2016 to 2022.

Market Insights

Rapid microbiological tests are gaining momentum on the global market as a reliable and cost-effective method for tracking and monitoring all types of microorganisms in pharmaceutical applications and other industrial settings. In addition, rapid microbiology tests offer faster and more accurate methods to help in the rapid detection of microbes and early diagnosis, saving costs and inventory. North America held the largest regional market, accounting for a market share of more than 36% in 2015, and is expected to dominate the global market for rapid microbiology tests in the 2016-2022 forecast period.

Browse Full Report Originally Published by Credence Research at

Large numbers of market-focused players providing a wider range of product portfolios are the key to the growth of the North American region. The Asia Pacific is expected to grow at the highest growth rate during the focus period, due to an increase in the number of laboratories in these regions and up-gradation of existing ones for automation of various instrumentation systems. Moreover, the market is wide open for advancing rapid diagnostic technologies to improve the turnaround time of the tests as compared to the conventional microbiology testing methods.

Among the technology types, the nucleic acid amplification technique held the largest share in the rapid microbiology tests in the pharmaceutical industry market due to its low cost and high efficacy. Moreover, the wide applications of nucleic acid amplification testing would further fuel the market growth in the coming years. Growth based detection technologies are anticipated to grow at the highest growth rate during the forecast period due to its faster turnaround time and accuracy in the detection of the microbes.

The sterility testing application held the largest share in the global rapid microbiology tests in the pharmaceutical market due to its wide application in the final drug product and other applications. Process water testing is anticipated to witness the highest growth in the global rapid microbiology tests in the pharmaceutical industry market during the forecast period of 2016 to 2022.

Access Free Sample Copy of Research Report:

[Note: Our Free Complimentary Sample Report Accommodate a Brief Introduction To The Synopsis, TOC, List of Tables and Figures, Competitive Landscape and Geographic Segmentation, Innovation and Future Developments Based on Research Methodology are also Included]

Market Segmentation

By End User Type

  • Raw material testing
  • In-process testing
  • Microbial limit testing
  • Bioburden assessment
  • Process water testing
  • Environmental monitoring
  • Sterility testing

By Technology Type

  • Immunology based Methods
  • Nucleic acid-based amplification tests
    • Polymerase Chain Reaction
    • Nucleic Acid Sequence-based amplification (NASBA)
    • Others
  • Mass Spectrometry based Methods
  • Flow Cytometry based Methods
  • Growth-based detection technologies
    • ATP-bioluminescence
    • Colorimeter detection
    • Autofluorescence detection
  • Biochemical Tests

By Geography Segment

  • North America (the U.S., Rest of North America)
  • Europe (U.K., Germany, France, Rest of Europe)
  • Asia Pacific (China, Japan, India, Rest of Asia Pacific)
  • Rest of World (Middle East & Africa (MEA), Latin America)

Access Free Sample Copy of Research Report:

Leave a Reply

Your email address will not be published. Required fields are marked *